Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: () Report Updated: Feb 08, 2016 | Print This Page

Get more stock ratings by Louis Navellier


Rating: Volatility:
Total Grade: Industry:

Stock Analysis

Rating: Monthly View

February March April May June July August September October November December January

Rating: Weekly View

This Week: down no change
Last Week: same no change
Two Weeks Ago: up no change
service keys

© quotemedia

Company Profile

Star Scientific, Inc., engages in the development, implementation, and licensing of tobacco curing technology that prevents the formation of carcinogenic toxins present in tobacco and tobacco smoke, primarily the tobacco-specific nitrosamines (TSNAs). It is also involved in the development, manufacture, marketing, and sale of very low-TSNA dissolvable smokeless tobacco products, including ARIVA compressed powdered tobacco cigalett pieces, STONEWALL Hard snuff, and modified risk tobacco products. In addition, the company develops, manufactures, markets, and sells nutraceutical dietary supplements, such as Anatabloc for anti-inflammatory support, and CigRx, a tobacco alternative for the maintenance of healthy metabolism. Further, it develops dietary supplements and pharmaceutical products that have a botanical-based component to treat tobacco dependence and a range of neurological conditions, including Alzheimerís disease, Parkinsonís disease, schizophrenia, and depression. The company sells its products through distributors in the United States. Star Scientific, Inc. was founded in 2000 and is based in Glen Allen, Virginia.

Recent News: